Found: 52
Select item for more details and to access through your institution.
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0696-z
- By:
- Publication type:
- Article
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine–rituximab.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 160, doi. 10.1111/bjh.19153
- By:
- Publication type:
- Article
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 5, p. 757, doi. 10.1111/bjh.17865
- By:
- Publication type:
- Article
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 539, doi. 10.1111/bjh.13637
- By:
- Publication type:
- Article
Diagnostic retinal biopsy in the management of secondary non-CNS vitreoretinal lymphoma masquerading as viral retinitis: a case report.
- Published in:
- International Journal of Retina & Vitreous, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40942-021-00327-3
- By:
- Publication type:
- Article
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 185, doi. 10.1007/s00277-023-05475-0
- By:
- Publication type:
- Article
The Role of the Comprehensive Geriatric Assessment in the Evaluation of the Older Cancer Patient.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 11, p. 458
- By:
- Publication type:
- Article
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 6, p. 303
- By:
- Publication type:
- Article
PI3K Inhibitors: Understanding Toxicity Mechanisms and Management.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 821
- By:
- Publication type:
- Article
A Plethora of Novel Therapies--Which One to Choose?
- Published in:
- Oncology (08909091), 2015, v. 29, n. 7, p. 499
- By:
- Publication type:
- Article
Peripheral T-Cell Lymphoma: What's the Role for Transplant?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 9, p. 891
- By:
- Publication type:
- Article
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1437, doi. 10.3390/cancers15051437
- By:
- Publication type:
- Article
Recent Approval of Pirtobrutinib for Mantle Cell Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 8, p. 431
- By:
- Publication type:
- Article
Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Role of allogeneic stem cell transplantation in mantle cell lymphoma.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 290, doi. 10.1111/ejh.12442
- By:
- Publication type:
- Article
Sequencing of Novel Therapies for Mantle Cell Lymphoma.
- Published in:
- Current Treatment Options in Oncology, 2021, v. 22, n. 12, p. 1, doi. 10.1007/s11864-021-00907-3
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 12, p. 861, doi. 10.1016/j.clml.2023.08.011
- By:
- Publication type:
- Article
Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
SOHO State of the Art Updates and Next Questions: Managing Relapsed Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 557, doi. 10.1016/j.clml.2022.01.008
- By:
- Publication type:
- Article
ABCL-040: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent Bruton's Tyrosine Kinase Inhibitor in Previously Treated Mantle Cell Lymphoma and Other Non-Hodgkin Lymphomas: Phase 1/2 BRUIN Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S378, doi. 10.1016/S2152-2650(21)01863-2
- By:
- Publication type:
- Article
HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S373, doi. 10.1016/S2152-2650(21)01854-1
- By:
- Publication type:
- Article
Poster: ABCL-040: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent Bruton's Tyrosine Kinase Inhibitor in Previously Treated Mantle Cell Lymphoma and Other Non-Hodgkin Lymphomas: Phase 1/2 BRUIN Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S241, doi. 10.1016/S2152-2650(21)01513-5
- By:
- Publication type:
- Article
Poster: HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S237, doi. 10.1016/S2152-2650(21)01489-0
- By:
- Publication type:
- Article
Management of Relapsed Mantle Cell Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare System.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Allogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S326, doi. 10.1016/j.clml.2017.07.136
- By:
- Publication type:
- Article
Association of Complex Karyotype with Inferior Survival in Mantle Cell Lymphoma is Independent of Specific Cytogenetic Abnormalities.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S377, doi. 10.1016/j.clml.2017.07.220
- By:
- Publication type:
- Article
Discordance Between the Prognostic Impact of MIPI and Overall Survival in a Multicenter Cohort of Patients with Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S115, doi. 10.1016/j.clml.2016.07.166
- By:
- Publication type:
- Article
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Efficacy and tolerability of anthracycline-based therapy in elderly patients with diffuse large B-cell lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Maxillofacial Anatomy: The Mandibular Symphysis.
- Published in:
- Journal of Oral Implantology, 2011, v. 37, n. 6, p. 745, doi. 10.1563/AAID-JOI-D-10-00136
- By:
- Publication type:
- Article
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: updated results from the phase 1/2 BRUIN study.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 33
- By:
- Publication type:
- Article
Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia.
- Published in:
- Case Reports in Hematology, 2012, p. 1, doi. 10.1155/2012/589718
- By:
- Publication type:
- Article
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01508-3
- By:
- Publication type:
- Article
GIFT4 fusokine converts leukemic B cells into immune helper cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The association of physical activity before and after lymphoma diagnosis with survival outcomes.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1543, doi. 10.1002/ajh.25288
- By:
- Publication type:
- Article
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 395, doi. 10.1002/ajh.24299
- By:
- Publication type:
- Article
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 395, doi. 10.1002/ajh.24299
- By:
- Publication type:
- Article
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 11, p. 1677, doi. 10.1002/cncr.28642
- By:
- Publication type:
- Article
Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 3, p. 377, doi. 10.1111/j.1365-2141.2011.08855.x
- By:
- Publication type:
- Article
Management of Older Adults with Mantle Cell Lymphoma.
- Published in:
- Drugs & Aging, 2020, v. 37, n. 7, p. 469, doi. 10.1007/s40266-020-00765-y
- By:
- Publication type:
- Article
Surveillance imaging during first remission in follicular lymphoma does not impact overall survival.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 18, p. 3390, doi. 10.1002/cncr.33660
- By:
- Publication type:
- Article
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.
- Published in:
- 2020
- By:
- Publication type:
- journal article